PeptideDB

Asaretoclax

CAS: 2363074-01-3 F: C47H57F2N7O7S W: 902.06

Asaretoclax is a potent B-cell lymphoma 2 (Bcl-2) inhibitor. Asaretoclax has the potential for the research of cancer.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Asaretoclax is a potent B-cell lymphoma 2 (Bcl-2) inhibitor. Asaretoclax has the potential for the research of cancer[1].
CAS 2363074-01-3
Formula C47H57F2N7O7S
Molar Mass 902.06
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. WHO Drug Information. Volume 38, No. 2.